Enhancement of the frequency and function of IL-10-secreting type i T regulatory cells after 1 year of cluster allergen-specific immunotherapy

International Archives of Allergy and Immunology

Volumn 159, Issue 4, 2012, Pages 391-398

  Lou, Wei ^a   Wang, Chengshuo ^a   Wang, Yang ^b   Han, Demin ^a,b   Zhang, Luo ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Allergic rhinitis; IL 10 secreting type I T regulatory cells; Immunoglobulin G4; Specific immunotherapy

Indexed keywords

ALUTARD; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 4; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; ALLERGEN SPECIFIC IMMUNOTHERAPY; ALLERGIC RHINITIS; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; LYMPHOCYTE FUNCTION; NASAL PRURITUS; NOSE OBSTRUCTION; OCULAR PRURITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRICK TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOALLERGOSORBENT TEST; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; RHINORRHEA; SAMPLING; SNEEZING;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; CELLS, CULTURED; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RHINITIS, ALLERGIC, PERENNIAL; T-LYMPHOCYTES, REGULATORY;

EID: 84864239746     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000338995     Document Type: Article

References (34)

1. Neukirch F, Pin I, Knani J, Henry C, Pison C, Liard R, et al: Prevalence of asthma and asthma-like symptoms in three French cities. Respir Med 1995; 89: 685-692. (Pubitemid 26001382)
2. Bousquet J, Van Cauvenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108(suppl 5):S147-S334.
3. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A: Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: Case-control study. J Allergy Clin Immunol 2007; 120: 381-387. (Pubitemid 47102376)
4. Jauregui I, Mullol J, Davila I, Ferrer M, Bartra J, del Cuvillo A, et al: Allergic rhinitis and school performance. J Investig Allergol Clin Immunol 2009; 19: 32-39.
5. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al: Longterm clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-475. (Pubitemid 29372886)
6. Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J: Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99: 450-453. (Pubitemid 27173080)
7. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S: Prevention of new sensitizations in asthmatic children mono-sensitized to house dust mite by specific immunotherapy: A six-year follow-up study. Clin Exp Allergy 2001; 31: 1392-1397. (Pubitemid 32823876)
8. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A, Koivikko A, et al: Specific immunotherapy has long-Term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62: 943-948. (Pubitemid 47037870)
9. Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, et al: CD4+ T-regulatory cells: Toward therapy for human diseases. Immunol Rev 2008; 223: 391-421. (Pubitemid 351986179)
10. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199: 1567-1575. (Pubitemid 38780411)
11. Akdis M: Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol 2006; 18: 738-744. (Pubitemid 44635172)
12. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, et al: IL-10 and TGF- cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205-1214. (Pubitemid 36609138)
13. Zhang L, Wang C, Han D, Wang X, Zhao Y, Liu J: Comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis. Int Ach Allergy Imm 2009, 148: 161-169.
14. Malling HJ: Immunotherapy as an effective tool in allergy treatment. Allergy. 1998; 53: 461-472.
15. Robinson DS: Th-2 cytokines in allergic disease. Br Med Bull 2000; 56: 956-968. (Pubitemid 32417162)
16. Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787. (Pubitemid 351707693)
17. Chatila TA: Role of regulatory T cells in human diseases. J Allergy Clin Immunol 2005; 116: 949-959.
18. Akdis M, Blaser K, Akdis CA: T regulatory cells in allergy: Novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005; 116: 961-968.
19. Akdis M, Akdis CA: Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov 2009; 8: 645-660.
20. Curotto de Lafaille MA, Lafaille JJ: Natural and adaptive foxp3+ regulatory T cells: More of the same or a division of labor? Immunity 2009; 30: 626-635.
21. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK: Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006; 212: 28-50. (Pubitemid 44116698)
22. Bullens DMA, De Swerdt A, Dilissen E, Kasran A, Kroczek RA, Cadot P, et al: House dust mite-specific T cells in healthy non-atopic children. Clin Exp Allergy 2005; 35: 1535-1541.
23. Van Overtvelt L, Wambre E, Maillère B, von Hofe E, Louise A, Balazuc AM, et al: Assessment of Bet v 1-specific CD4+ T cell responses in allergic and non-allergic individuals using MHC class II peptide tetramers. J Immunol 2008; 180: 4514-4522.
24. Han D, Wang C, Lou W, Gu Y, Wang Y, Zhang L: Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4+CD25+Foxp3+ T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis. Clin Immunol 2010; 136: 292-301.
25. Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Müller U, et al: Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996; 98: 1676-1683. (Pubitemid 26327879)
26. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K: Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106. (Pubitemid 28323835)
27. Francis JN, Till SJ, Durham SR: Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003; 111: 1255-1261. (Pubitemid 36683679)
28. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, et al: IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205-1214. (Pubitemid 36609138)
29. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C: Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific Tcell tolerance, and immune deviation. J Allergy Clin Immunol 2007; 120: 707-713. (Pubitemid 47320765)
30. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY: IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998; 160: 3555-3561. (Pubitemid 28164751)
31. Van Ree R, Van Leeuwen WA, Dieges PH, Van Wijk RG, De Jong N, Brewczyski PZ, et al: Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy. Clin Exp Allergy 1997; 27: 68-74. (Pubitemid 27051365)
32. Gleich GJ, Zimmermann EM, Henderson LL, Yunginger JW: Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: A six-year prospective study. J Allergy Clin Immunol 1982; 70: 261-271. (Pubitemid 12036066)
33. Reisinger J, Horak F, Pauli G, van Hage M, Cromwell O, et al: Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. J Allergy Clin Immunol 2005; 116: 347-354. (Pubitemid 41096542)
34. Meiler F, Klunker S, Zimmermann MC, Akdis A, Akdis M: Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and tolllike receptors. Allergy 2008; 63: 1455-1463.